Anti-Xa testing for pediatric and neonatal patients on extracorporeal membrane oxygenation.
Perfusion（2023）
Abstract
Anti-Xa testing is associated with improved outcomes among cardiac indicated and neonatal patients on ECMO. Additional research to find the optimal heparin monitoring regimen is needed to better support these critically ill patients. In the interim, we recommend clinicians consider utilizing anti-Xa assays as part of their heparin monitoring plan for neonatal and cardiac indicated patients on ECMO.
MoreTranslated text
Key words
ECMO, anticoagulation, PICU, cardiac ICU, NICU, cardiac and circulatory failure
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined